Avai Bio, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVAI research report →
Companyavaibio.com
Avai Bio, Inc. is a holding company, which focuses on websites and mobile apps aimed to provide customization and convenience for its users. It engages in completing relevant tasks in IT consulting and introducing artificial intelligence to regular users.
- CEO
- Chris Winter
- IPO
- 2020
- Employees
- 1
- HQ
- Vilnius, NV, LT
Price Chart
Valuation
- Market Cap
- $33.18M
- P/E
- -32.15
- P/S
- 0.00
- P/B
- -11.85
- EV/EBITDA
- -36.49
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 47.64%
- ROIC
- 75.66%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,142,115 · 46.34%
- EPS
- $-0.01 · 63.82%
- Op Income
- $-1,532,792
- FCF YoY
- 21.12%
Performance & Tape
- 52W High
- $0.83
- 52W Low
- $0.23
- 50D MA
- $0.33
- 200D MA
- $0.39
- Beta
- 0.92
- Avg Volume
- 108.04K
Get TickerSpark's AI analysis on AVAI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AVAI Coverage
We haven't published any research on AVAI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AVAI Report →